Philipps-Universität Marburg

Marburg 35043

2 studies enrolling now · 8 studies all time

What they study most

Focal Epilepsy, Focal Onset Seizures, Neuroendocrine Tumors, Parkinson's Disease, Primary Generalized Tonic-Clonic Seizures, Progressive Supranuclear Palsy, Tonic-Clonic Seizures, Vitreomacular Adhesion

Studies at this site

• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
• Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients — Running, not enrolling
• A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease — Running, not enrolling
• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures — Completed
• Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial. — Completed
• Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD) — Completed
• Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy — Completed